AngioDynamics reports Q1 sales of $80.9M, appoints new CEO
AngioDynamics posted Q1 FY27 net sales of $80.9M (+6.9% YoY), with gross margin of 59.4% and an adjusted net loss of $1.8M. The company reiterated FY27 guidance and said Eric Honroth will become CEO effective Nov. 2, 2026.
Story updates
10:04:37 AM UTC
SquawkNews
AngioDynamics Sees FY27 Adj Loss/Shr 29c-Adj Loss/Shr 24c >ANGO
8M. The company reiterated FY27 guidance and said Eric Honroth will become CEO effective Nov. 2, 2026.